Introduction
Hibernation is essential for survival during seasonal deficiencies in food supply in several diverse lineages of mammals (Carey et al., 2003; Dausmann et al., 2004; Heldmaier et al., 2004) . Survival is achieved by severe metabolic suppression, termed torpor, where rates of O 2 consumption fall to as low as 1% of resting metabolic rate and core body temperature (T b ) falls to as low as Ϫ3°C (Barnes, 1989; Geiser, 2004; Heldmaier et al., 2004) . Torpor in hibernating mammals thus defines the nadir of mammalian metabolism and T b , but mechanisms regulating initiation of torpor have been poorly understood Drew et al., 2007) . Transition into the torpid state has been postulated to include three processes: (1) altered CNS control of thermoregulatory processes and an extension of sleep (Walker et al., 1977 (Walker et al., , 1980 , (2) active inhibition of metabolism such as inhibition of mitochondrial oxidative phosphorylation (Muleme et al., 2006) , and (3) temperaturedependent effects on metabolic rate, or "Q 10 effects" (Geiser, 2004) . For larger mammals, the debate has centered more extensively on CNS control versus active suppression of metabolism via modulation of biochemical processes within metabolically active tissues.
In seasonal (obligate) hibernators, such as the arctic ground squirrel (AGS; Urocitellus parryii), torpor depends on a circannual cycle. The circannual cycle persists under constant photoperiods with food provided ad libitum (Heller and Poulson, 1970; Pengelley et al., 1976; Lee and Zucker, 1991) . The seasonal character of hibernation thus provides a clue to its regulation. Once torpor ensues animals rewarm spontaneously every 2-3 weeks for brief (12-24 h) periods of normal body temperature (termed euthermy). This cycle continues until torpor ceases to occur in the spring. A two-switch model suggests that one physiological switch initiates the onset of the hibernation season and another switch initiates the onset of torpor (Serkova et al., 2007) . The role of the CNS or the nature of the signaling events involved in either of these two switches have been unknown. Central purinergic signaling via A 1 adenosine receptors (A 1 ARs) mediates sleep drive (Benington et al., 1995; Porkka-Heiskanen and Kalinchuk, 2011) and decreases body temperature (Miller and Hsu, 1992; Barros et al., 2006) , and more recently, endogenous adenosine within the CNS has been found to decrease body temperature at presumed torpor onset in hamsters (Mesocricetus auratus) (Shiomi and Tamura, 2000; Tamura et al., 2005) . Here we used intracerebroventricular drug administration to test the hypothesis that a seasonal change in purinergic signaling within the CNS is necessary for the onset of spontaneous torpor in the AGS, a seasonal hibernator. We show for the first time that activation of A 1 AR within the CNS is necessary and sufficient to induce torpor in AGS during the hibernation season, but not during the offseason, when AGSs do not spontaneously hibernate. The CNS and purinergic signaling are therefore key regulators of torpor onset, and sensitization to the effects of endogenous adenosine serves as a seasonally regulated switch that facilitates A 1 ARmediated torpor.
Materials and Methods
Animals. Procedures were approved by the University of Alaska Fairbanks Institutional Animal Care and Use Committee and Department of Defense Animal Care and Use Review Office. AGSs were captured near 66°38ЈN, 149°38ЈW under permit from the Alaska Department of Fish and Game. Animals were fed rodent chow and housed at 20°C with natural lighting for their wild-trapped latitude until mid-August, when they were moved to environmental chambers set to 2°C and 4:20 h light: dark (L:D). AGSs remained in these conditions until the end of the study. The hibernation season was defined by the presence of spontaneous torpor. The off-hibernation season (off-season) was defined by an absence of spontaneous torpor. Torpor was monitored daily by placing shavings on the animals' backs.
Surgery. Under sterile conditions, telemetry transmitters (model VM-FH, MiniMitter, or model CTA-F40, Data Sciences International) were implanted under isoflurane anesthesia. The head was leveled in a rat stereotaxic frame (Stoelting). Copalite (Cooley & Cooley) was applied to the skull. A target was marked at AP EBZ ϩ8.5 mm, L EBZ ϩ3.0 mm, the arm was tilted 15°, and the cannula tip was repositioned on the target. An internal cannula extending 1.0 mm beyond the guide cannula was connected to a syringe primed with sterile saline. The cannula assembly was lowered 5.5 mm from the brain surface and retracted until CSF was withdrawn. The guide cannula was secured to anchoring screws (Stoelting) and plugged with a dummy cannula (Plastics One). Animals received enrofloxacin (Bayer Health Care) (5 mg/kg, s.c., BID for 3 d), and ketoprofen (Fort Dodge Animal Health, 1 mg/kg, QD, s.c., for 3 d total). When CTA-F40 transmitters were used, animals received buprenorphine (Hospira, 0.03 mg/kg, QD, i.m., for 3 d) and 2 weeks separated transmitter surgery and intracerebroventricular cannula surgery. Following surgery, animals were housed at 20°C 4:20 h L:D and wounds were cleaned for 10 d before returning to environmental chambers at 2°C. Surgery was performed at least 1 month before drug testing.
O 2 consumption and body temperature. A cylindrical Plexiglas metabolic chamber (diameter 28 cm, height 23 cm) on a rat-turn (Bioanalytical Systems) was positioned over a telemetric receiver and T b was acquired using DataQuest software A.R.T.2.3 (Data Sciences International). Air was drawn from a gas-tight swivel at the bottom of the chamber, filtered, and passed through a mass flow controller at 3 L/min (Model 840, 0 -5 L/min, Sierra Instruments), and a subsample was passed through a multiplexing valve system and dried by a Nafion drier used in reflux mode (model PD-50T-24-PP, Perma Pure) before passing through the O 2 and CO 2 analyzers (Model FC-1B and CA-2A, Sable Systems International). The automated data acquisition and analysis software (LabGraph, developed by Tøien) interpolated between calibrations. O 2 consumption was corrected for respiratory volume change according to the principles of the Haldane transformation (Wagner et al., 1973; Karpovich et al., 2009) . The integrity of the system was tested during and after the study period by burning 100% ethanol. Measured O 2 consumption was within 4% of that calculated from the weight loss of the lamp.
For monitoring subcutaneous temperature following intraperitoneal CHA injections, animals were implanted with IPTT-300 transponders (Bio Medic Data Systems), subcutaneously between the scapula. T b was monitored using a telemetry system (DAS-6000; Bio Medic Data Systems) in the home cage every 30 -60 min for at least 1 h before drug injection and every 1 h after injection for 4 h and again 30 h after intraperitoneal injection of CHA. Because the IPTT transponders are not reliable below ϳ30°C, to confirm minimal T b at 30 h, rectal temperature was monitored with a thermocouple (Model H H21 Microprocessor Thermometer, Type J-K-T Thermocouple, OMEGA Engineering) in animals that were torpid after 30 h.
Drug administration. Animals tested for drug-induced torpor were aroused on day 3 or 4 of a torpor bout and moved from the environmental chamber (2°C, 4:20 L:D) to a warmer room (20°C, 4:20 L:D), where they remained overnight. On the following day, they were handled as described below and placed in the metabolic chamber for baseline recordings for at least 1 h before drug administration. For intracerebroventricular administration of CHA, injection cannulae primed with CHA or vehicle by an observer unaware of treatment were connected to a perfusion pump (Harvard Apparatus). Euthermic animals were lightly anesthetized with isoflurane as described for surgery and fit with a harness and injection cannula in a way that allowed animals to move freely within the metabolic chamber. After recovery from anesthesia, baseline O 2 consumption and T b were collected for 1 h before delivering the drug (0.5 nmol CHA/10 l, delivered over 1 min) or vehicle (10 l, delivered over 1 min). The cannula was left in place and O 2 consumption and T b were monitored for at least 24 h or until T b was stable. Solutions used to dissolve the drugs (vehicle) were administered in a balanced cross-over design by an observer unaware of treatment. In this way, half of the animals received drug on the first test and vehicle on the second test and the other half received vehicle on the first test and drug on the second. Drug and vehicle tests were separated by at least 1 week. In a separate group of animals, a Y-injection cannula (Plastics One) was primed with 2-Cl-IB-MECA (3 nmol/10 l), and the secondary line was primed with CHA (0.5 nmol/10 l). Animals were treated as above except that the injection of 2-Cl-IB MECA (10 l, delivered over 1 min) was followed by a second injection of CHA (3.3 l to clear the cannula of 2-Cl-IB MECA, then 10 l of CHA at 10 l, delivered over 1 min).
Additional animals received pentobarbital (20 mg/kg, i.p.) during the midseason or off-(nonhibernating) season and T b and O 2 consumption were monitored as described above. To ensure that the stress of intraperitoneal injections did not interfere with drug-induced torpor, a separate group of AGSs was administered CHA intraperitoneally during midseason.
For antagonist studies, torpid AGSs were habituated to handling before drug testing. During habituation, AGSs were handled daily to mimic handling necessary for the experiment until handling failed to induce arousal. At the next signs of torpor when T b dipped to ϳ34°C, AGSs were fit with a harness and an injection cannula primed with antagonist (CPT, 3.0 nmol/10 l) or vehicle by an experimenter unaware of treatment and onset of torpor proceeded without interruption. When T b reached 10°C, 10 l was delivered over 1 min and the cannula was left in place for an additional 24 h. MSX-3 (3.0 nmol/10 l) was administered in the same way to another group of animals. The 3 nmol dose of MSX-3 was considered to be equipotent to the 3 nmol dose of CPT since MSX-2 has This indicates that A 1 AR activation is necessary for torpor onset. b, Vehicle had no effect in any of the animals tested. Results are shown as means and SEM; n ϭ 6 AGSs. similar affinity for the A 2a AR as CPT has for the A 1 AR. The 3 nmol dose of 2-Cl-IB MECA was considered to be higher than an equipotent dose of 0.5 nmol of CHA since 2-Cl-IB MECA has a slighter higher affinity for A 3 AR than CHA has for A 1 AR (Bruns et al., 1986; Klotz, 2000; Sauer et al., 2000; Solinas et al., 2005) .
Drugs. N 6 -Cyclohexyladenosine (CHA), 8-cyclopentyltheophylline (CPT), and phosphoric acid mono-(3-{8-[2-(3-methoxyphenyl) vinyl]-7-methyl-2,6-dioxo-1-prop-2-ynyl-1,2,6,7-tetrahydropurin-3-yl}propyl) ester disodium salt (MSX-3) hydrate were purchased from Sigma-Aldrich, and 2-chloro-N 6 -(3-iodobenzyl) adenosine-5Ј-N-methyluronamide (2-Cl-IB MECA) was purchased from Tocris Bioscience. CHA was dissolved in 0.01 M phosphate buffer, CPT and 2-Cl-IB-MECA were dissolved in 1% DMSO, and MSX-3 hydrate was dissolved in water. All solutions were sterilized by 0.2 m filtration before use except for pentobarbital sodium, which was obtained as an injectable solution (50 mg/ml) (Abbott Laboratories).
Results

Onset of torpor requires A 1 AR activation
To investigate whether A 1 AR activation by endogenous adenosine within the CNS is necessary for the onset of spontaneous torpor in AGS, the A 1 AR antagonist CPT (3 nmol/10 l) was administered into the lateral ventricle during onset of spontaneous torpor, via an indwelling intracerebroventricular cannula. CPT, delivered by an investigator unaware of treatment, reversed torpor onset in all animals tested, while vehicle had no effect (Fig. 1) .
Sensitivity to the torpor-inducing effects of the A 1 AR agonist CHA increases as the hibernation season progresses
We next asked whether A 1 AR activation within the CNS was sufficient to induce a state of torpor that mimicked spontaneous torpor both in temporal profile and in magnitude of decline in the rate of O 2 consumption and T b . We also investigated whether the sensitivity to torpor-inducing effects of CHA, an A 1 AR agonist, would increase as the hibernation season progressed. Six AGSs instrumented with intracerebroventricular cannula open to the lateral ventricle were administered CHA (0.5 nmol/10 l) or vehicle in a blinded, balanced, cross-over fashion at three times of the year. These three tests commenced during the off-season when AGSs were not displaying spontaneous torpor, during the early hibernation season after all AGSs had begun to display spontaneous torpor, and during the middle of the hibernation season.
CHA administered during the off-season, induced a slight, temporary, reduction in O 2 consumption and T b in all AGSs tested (Fig. 2a,g ). Early in the hibernation season the same dose of CHA delivered to the same six AGSs induced a torpor-like decline in O 2 consumption and T b in two of six animals tested (Fig. 2b,h ) and an off-season-like response in the remaining four animals (Fig. 2c,i) . By mid-hibernation season (midseason), the same dose of CHA induced a torpor-like response in all of these same six animals (Fig. 2d,j) . The torpor-like response to CHA resembled spontaneous entry into torpor (Fig. 2e,k) . Pentobarbital (20 mg/kg, i.p.) produced an off-season-like response regardless of season (Fig. 2f,l) . Vehicle (phosphate buffer, i.c.v. for CHA or saline, i.p. for pentobarbital) did not produce a notable effect on T b or rate of O 2 consumption at any season tested (Fig. 3) .
We asked whether characteristics such as body weight, sex, age, and timing or evidence of prior torpor bouts predicted the magnitude or quality of the CHA-induced response during the early hibernation season. The two animals that displayed CHAinduced torpor when tested early in the season (Early season) had exhibited slightly more bouts of spontaneous torpor before this CHA test than the other four animals (Table 1) . Other variables did not predict the larger response to CHA in these animals. Data shown in Table 1 illustrate that the hibernation season was defined by the presence of spontaneous torpor. In these animals, progression of the hibernation season was evident from the number of torpor bouts noted since the onset of spontaneous torpor. The circannual cycle of obligate hibernators, such as AGS, will free run when animals are housed under constant L:D conditions (Pengelley et al., 1976; Lee and Zucker, 1991) . This free-running circannual cycle explains why the first day of spontaneous torpor occurred in July in many of the animals in this study.
CHA-induced and spontaneous torpor is specific to A 1 AR
Although CHA is fairly selective for A 1 AR, it has some affinity for A 3 AR (Gao et al., 2003) , leading us to ask whether A 3 AR activation could account for CHA-induced torpor. The A 3 AR agonist 2-Cl-IB-MECA (3 nmol/10 l, i.c.v.), delivered during midseason, failed to induce torpor in any of the animals tested, although a subsequent injection of CHA (0.5 nmol/10 l, i.c.v.) induced torpor as observed previously (Fig. 4a) , indicating that A 3 AR activation is not sufficient to induce torpor. Both A 1 AR and A 2a AR play a role in sleep (Porkka-Heiskanen et al., 1997; Huang et al., 2005; Oishi et al., 2008) ; and torpor is in part an extension of sleep (Walker et al., 1977) . We therefore asked whether A 2a AR receptors contribute to the onset of torpor. MSX-3, a water-soluble prodrug of the selective, high-affinity A 2a AR antagonist MSX-2 (Solinas et al., 2005) , failed to reverse onset of spontaneous torpor in any of the animals tested (Fig. 4b) . These results indicate that A 2a AR activation is not necessary for torpor onset.
Pentobarbital is a positive allosteric modulator of GABA A receptors, promotes sleep, and shows seasonal-dependent changes in efficacy across the hibernation season in thirteen-lined ground squirrels (Hengen et al., 2011) . To investigate whether the seasonal change in response to CHA-induced torpor was specific to an adenosine agonist, pentobarbital was administered during the midseason and off-season. Pentobarbital was administered, intraperitoneally, to two groups of animals. One group was tested during the off-season, when animals failed to demonstrate spontaneous torpor. Another group was tested during the mid-hibernation season, when the total number of bouts of spontaneous torpor ranged between 12 and 16 bouts. Figure 2 , f and l, shows that pentobarbital failed to induce torpor at any AGS treated with CHA (0.5 nmol, i.c.v) Column heads are AGS ID numbers.
season tested. Table 2 shows that the characteristics of AGSs treated with pentobarbital during these two seasons are similar to the off-season and midseason groups of AGSs treated with CHA. Injections of pentobarbital, i.p., were noted to produce a brief, but detectible, increase in V O 2 that was not noted with intracerebroventricular administration of CHA (Fig. 2f ) . To ensure that intraperitoneal injections did not interfere with drug-induced torpor, separate groups of AGSs were treated with CHA (0.5 mg/kg, i.p.) during the off-season and during the midseason. Data shown in Table 3 show that intraperitoneal injections of CHA induced torpor during the midseason, but not during the off-season as seen for intracerebroventricular administration. Characteristics of AGSs were similar to other groups of animals tested during these two seasons.
Discussion
These results indicate that the CNS regulates the onset of torpor via activation of A 1 AR. Sensitivity to the torpor-inducing effects of the A 1 AR agonist CHA increases as the hibernation season progresses, and the torpor-inducing efficacy of CHA is specific to A 1 AR activation. It is unlikely that the seasonal response to CHA was due to differences in cold adaptation, since animals were housed at 2°C throughout the study period. Torpor in hibernating animals represents an extreme example of decreased metabolism, but the central or peripheral sites or signaling mechanisms involved in torpor onset have been unknown . By administering purinergic ligands specific for the adenosine A 1 , A 2a , or A 3 receptors (Table 4) into the lateral ventricle of AGSs at various times across the annual hibernation cycle, we find that adenosine within the CNS meets all of the necessary requirements for an endogenous mediator of torpor in AGS. A progressive increase in the sensitivity of AGS to A 1 AR-mediated signaling within the CNS parallels the seasonal transition into the hibernation phenotype and provides an example of a seasonal switch proposed in the two-switch model for obligate hibernation (Serkova et al., 2007) . We show that in the context of this model, increased gain in central purinergic signaling serves as the first switch, and stimulation of central A 1 AR by endogenous adenosine serves as a second switch, that induces torpor (Fig. 5) .
Because A 1 AR activation is necessary for the homeostatic sleep response (Bjorness et al., 2009) , an increased gain in purinergic signaling predicts an increase in sleep drive during the hibernation season. Although sleep drive has not been monitored in AGS, golden-mantled ground squirrels sleep more during the hibernation season (Walker et al., 1980) . Prolonged torpor in hibernating mammals is distinguished by at least three distinct processes that include onset of torpor, maintenance of torpor, and arousal from torpor (Drew et al., 2007) . In hamsters (M. auratus), A 1 AR activation is necessary for torpor onset, as shown here for AGS, but is not necessary to maintain prolonged torpor (Tamura et al., 2005) . Seasonal alter- Bruns et al. (1986) ; b Solinas et al. (2005) ; c Sauer et al. (2000) ; d Gao et al. (2003) ; e van Galen et al. (1994) ; f Kim et al. (1994) ; h, human recombinant receptors; n.a., not available. Figure 5 . Enhanced purinergic signaling turns on the seasonal switch to hibernate in arctic ground squirrels. Schematic diagram modified from the two-switch model of Serkova et al. (2007) illustrates how seasonal sensitization of purinergic signaling primes the brain for adenosine-induced torpor during the hibernation season. The off-season, commonly referred to as the "summer-active" season, is indicated by a white background. During the off-season, overflow of adenosine that occurs as part of normal purinergic signaling fails to induce torpor. Here we use homeostatic sleep drive as an example of normal purinergic signaling (PorkkaHeiskanen et al., 1997; Basheer et al., 2004 ). The present report shows that an increase in the gain in purinergic signaling occurs during the hibernation season. The hibernation season is indicated by a dark background and the shading from light to dark illustrates an increase in gain in purinergic signaling as the season progresses. This increased gain in purinergic signaling during the hibernation season primes the brain such that overflow of endogenous adenosine with subsequent activation of A 1 AR now induces torpor. The effect of endogenous adenosine is demonstrated by the ability of an A 1 AR antagonist (CPT) to reverse onset of spontaneous torpor.
ations in signaling events involved in torpor maintenance or interbout arousal are as yet unclear. Moreover, while the present results demonstrate that A 1 AR activation is necessary and sufficient to induce torpor in AGS, it is unlikely that adenosine is the only neuromodulator involved with torpor onset.
The present results clearly show that A 1 AR stimulation is sufficient to initiate torpor onset that results in a decrease in metabolic rate to levels that are below basal metabolic rate, a value determined to be within 0.40 and 0.61 ml ⅐ g Ϫ1 ⅐ h Ϫ1 for AGS (Scholander et al., 1950; Withers et al., 1979) . Geiser (2004) describes a scenario in which decreased thermogenesis leads to cooling, which then via thermodynamic effects decreases oxygen consumption to torpid metabolic rates. This scenario may account for how central A 1 AR-induced inhibition of thermogenesis in AGS could lead to a consequent lowering of T b that is then sufficient to account for torpid metabolic rates reported here. This explanation incorporates two of three proposed mechanisms of metabolic suppression in hibernating animals. One mechanism includes the central inhibition of thermogenesis associated with a lowering of brain temperature necessary to induce thermogenesis . A second mechanism involves thermodynamic effects of cooling on metabolic rate described by the Van't Hoff equation (Atkins and De Paula, 2006) . In biological systems, temperature effects are often referred to as Q 10 effects, where reaction rates generally double or triple with every 10°C increase in temperature (Schmidt-Nielsen, 1997) . A third set of mechanisms involves "active" suppression of cellular processes such as ion channel arrest (Hochachka, 1986) or inhibition of cellular respiration (Muleme et al., 2006) . It is difficult to explain how central A 1 AR activation could directly cause global, "active" suppression of cellular processes; however, global effects could occur downstream to torpor initiation.
Given that cooling contributes to metabolic rate reduction, cooling during onset of torpor will influence the subsequent decrease in metabolic rate. Unexpectedly, a rapid rate of cooling induced by CHA during the off-season contrasted with a significantly slower rate of cooling induced by CHA during the hibernation season. All animals had been housed at 2°C for several months, so cold adaptation is unlikely to account for differences in the rate of cooling. O 2 consumption and T b were measured in the present study as physiological parameters used to clearly distinguish torpor onset from hypothermia. Since thermoregulatory systems are independently regulated, further study of multiple thermoeffector activities is warranted to achieve a more complete understanding of torpor as a thermoregulatory response (Romanovsky, 2007; Nakamura et al., 2009) .
The mechanism that increases the gain in purinergic signaling may involve changes in receptor expression or function, changes in extracellular levels of adenosine, or changes in neural circuits regulating sleep, metabolism, or body temperature. Seasonal changes in sensitivity to allosteric modulation of GABA A receptors by pentobarbital in thirteen-lined ground squirrels have been observed. These changes are restricted to cardiorespiratory neurons and are associated with altered expression of and ␦ GABA A receptor subunits (Hengen et al., 2009 (Hengen et al., , 2011 . In the present study, pentobarbital did not induce torpor; however, a role for altered allosteric modulation of GABA A R in adenosinemediated torpor induction cannot be ruled out.
The capacity of an A 1 AR agonist to induce a torpid state may confer some of the neuroprotective aspects of hibernation noted previously (Zhou et al., 2001 ). Central A 1 AR stimulation prevents cardiac arrhythmias during cooling in hamsters (Miyazawa et al., 2008) and may offer a means to avoid cardiac arrhythmias or other side effects encountered during therapeutic hypothermia (Polderman and Herold, 2009 ). H 2 S-induced suspended animation has led to investigation of H 2 S as a therapeutic agent (Blackstone et al., 2005) . Likewise, understanding how hibernating mammals regulate metabolic suppression has potential to translate to improved therapies for conditions in which oxygen and energy supply fail to meet demand. Such conditions include stroke, cardiac arrest, hemorrhagic shock, and trauma.
